Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Acute 1 Glioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 41 fludarabine 31 Dexamethasone 27 venetoclax 24 Cytarabine 22 Rituximab 16 pembrolizumab 15 fludarabine phosphate 14 Filgrastim 12 Etoposide 12 Lenalidomide 11 Vincristine 10 Gemcitabine 10 Azacitidine 10 pomalidomide 9 Interleukin-2 9 Granulocyte Colony-Stimulating Factor 9 Doxorubicin 9 Calcium Dobesilate 9 carfilzomib 8 Topotecan 8 Nivolumab 8 Methotrexate 8 Everolimus 8 Decitabine 8 Bortezomib 8 Melphalan 7 Cisplatin 7 Vorinostat 6 Injections 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recurrence × Gadolinium × Clear all

NCT03154996 2026-04-22

Chronic Convection Enhanced Delivery of Topotecan

Columbia University

Phase 1 Completed

Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡